Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Strategy Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Strategy Inc. trades at $139.38 (market cap $60.65B). The key difference: Strategy Inc. is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals.
| GEHC | MSTR | |
|---|---|---|
Market Cap | $30.93B | $60.65B |
Volume | 5,033,451 | 20,701,924 |
Sector | Health | Technology |
52-Week High | $88.16 | $301.91 |
52-Week Low | $59.48 | $82.31 |
Enterprise Value | $39.39B | $79.42B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 113 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
MSTR stock trades at $152.18, down 0.33% on the day, with a neutral technical signal and mixed earnings history. The company reported a net loss of $3.85 billion in 2025 despite $477.23 million in revenue, reflecting a negative net income margin of -6,102.96%. Analyst consensus remains bullish with a $253.36 price target, but cash flow from operations is negative, and the stock faces volatility linked to its Bitcoin holdings.
The outlook hinges on Bitcoin price trends and operational execution, with significant upside potential per analyst targets but high risk from sustained losses and debt. Investors must weigh the bullish sentiment against fundamental weaknesses and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
